Proton Pump Inhibitors also known as PPI’s are medicines. Generally, it is known to alleviate the symptoms of heartburn and gastroesophageal reflux disease (GERD). The medical industry calls its an inhibitor because it stops the acid protection in the body that gives way to create these types of symptoms. That is, it inhibits the gastric proton pump at the end of the process of acidic production.
Different kinds of these so-called Proton Pump Inhibitors exist on the market. These PPI medicines are known as:
The lawsuits have been filed against the pharmaceutical drug makers because the patients noticed they suffered from the following after use of such products:
- Kidney Injury
- End Stage Renal Failure
- Bone Fractures
- Cardiovascular Disease
- Esophogeal Cancer
- Bone Injury
The issue is inadequate warnings – that the drugmakers did not place proper warnings on the labels so that the consumer could make an informed choice when deciding to take these PPI drugs.
Potential Defendants: They include well-known companies like AstraZeneca, Takeda, and Pfizer. These corporations have already been sued and your case might involve them as well.
PPI makers have not recalled all of these drugs because litigation is still in progress under MDL litigation also known as Multi-District Litigation. The difficulty with these lawsuits is that they are also known to help and not harm patients with their symptoms.